2023 BioTech Life Science Telehealth 
Lloyd Price
SEPTEMBER 2, 2023
Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.
Health Populi
MAY 4, 2023
Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S. we see an over-indexing of office, institutional and telehealth visits (at 108) and a 104 gauge on new prescriptions. is always a detailed, deep, and insightful dive into the state of prescription drugs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
OCTOBER 11, 2023
Welcome to the special HLTH 2023 edition of Healthcare IT Today Bonus Features. ” Google Cloud released new capabilities in Vertex AI Search for healthcare and life sciences, highlighting Hackensack Meridian Health and Highmark Health in its announcement. Additionally, ambient sensor vendor care.ai
Healthcare IT Today
JANUARY 8, 2024
The excitement around new tools took hold of all industries in 2023, and the potential is expansive. In 2023, Pear Therapeutics filed for bankruptcy and Akili abandoned the prescription business model. Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety.
Digital Health Global
NOVEMBER 20, 2023
With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. Accessed November 2023. Accessed November 2023. Available at: [link]. McKinsey & Company. Available at: [link].
Expert insights. Personalized for you.
61 
Let's personalize your content